High pro­file biotech in­vestor Beth Sei­den­berg is ex­it­ing Klein­er Perkins and start­ing her own fund — re­port

Beth Sei­den­berg is jump­ing out of her high pro­file role as a gen­er­al part­ner at Klein­er Perkins to start her own life sci­ences fund.

Re­code re­port­ed that Sei­den­berg, one of the high­est pro­file ex­ecs in the life sci­ences VC com­mu­ni­ty, has be­gun rais­ing mon­ey for the new fund, which will fo­cus on biotech and health. Fundrais­ing puts her in a qui­et pe­ri­od, un­able to dis­cuss plans.

“I can’t,” Sei­den­berg told me when I reached her this morn­ing and asked for some en­light­en­ment. She cit­ed SEC rules re­quir­ing her to stay mum about any plans for now.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER